N-able (NABL) files Form 144 for 34,568-share sale via Morgan Stanley
Rhea-AI Filing Summary
N-able, Inc. (NABL) Form 144 notice reports a proposed sale of 34,568 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $266,190.88. The filing lists the shares as previously received as restricted stock in four tranches between 11/03/2022 and 05/21/2024, totaling the 34,568 shares to be sold. The company has 187,096,094 shares outstanding, and no securities were reported sold by the filer in the past three months. The filer certifies they are unaware of any undisclosed material adverse information and references Rule 144 and potential 10b5-1 plans.
Positive
- Full disclosure of broker, share count, and acquisition history enables investor transparency
- Filer certifies no undisclosed material adverse information, reducing informational asymmetry
- No reported sales in the past three months, limiting near-term insider selling pressure
Negative
- Insider proposes to sell 34,568 shares, which could be perceived negatively by some investors despite small size
- Aggregate market value $266,190.88 indicates a non-zero liquidity event by an insider
Insights
TL;DR: Routine insider notice for a modest proposed sale; not material to capitalization.
The filer intends to sell 34,568 shares valued at $266,190.88 via Morgan Stanley on the NYSE. Compared with the reported 187,096,094 shares outstanding, this sale represents a very small fraction of total equity, indicating limited dilution or market impact. The securities were acquired as restricted stock across four dates, consistent with compensation vesting. The filer affirms no undisclosed material information and notes Rule 144 compliance; if a 10b5-1 plan exists it would formalize planned sales, reducing signaling risk.
TL;DR: Procedural disclosure aligns with standard insider selling and Rule 144 requirements.
The Form 144 provides required broker, amount, and acquisition history details for the proposed sale. The separate acquisition entries from 2022–2024 show the shares originated from restricted stock grants, a common executive compensation mechanism. The absence of sales in the prior three months and the filer’s representation about material information are important governance elements that support transparency. Overall, the filing reads as a standard, compliant disclosure rather than a governance red flag.